These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18518827)

  • 1. Inhaled prostanoids in the therapy of pulmonary hypertension.
    Gessler T; Seeger W; Schmehl T
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):1-12. PubMed ID: 18518827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin therapies for the treatment of pulmonary arterial hypertension.
    Gomberg-Maitland M; Olschewski H
    Eur Respir J; 2008 Apr; 31(4):891-901. PubMed ID: 18378784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
    Gessler T; Seeger W; Schmehl T
    Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized vasodilators in pulmonary hypertension.
    Gessler T; Schmehl T; Olschewski H; Grimminger F; Seeger W
    J Aerosol Med; 2002; 15(2):117-22. PubMed ID: 12184861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostanoids in the treatment of pulmonary arterial hypertension].
    Başkurt M; Küçükoğlu MS
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin and its analogues in the treatment of pulmonary hypertension.
    Olschewski H; Rose F; Schermuly R; Ghofrani HA; Enke B; Olschewski A; Seeger W
    Pharmacol Ther; 2004 May; 102(2):139-53. PubMed ID: 15163595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
    Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
    Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostanoids for pulmonary arterial hypertension.
    Galiè N; Manes A; Branzi A
    Am J Respir Med; 2003; 2(2):123-37. PubMed ID: 14720012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled iloprost for the control of pulmonary hypertension.
    Krug S; Sablotzki A; Hammerschmidt S; Wirtz H; Seyfarth HJ
    Vasc Health Risk Manag; 2009; 5(1):465-74. PubMed ID: 19475782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pathophysiology and therapy of pulmonary hypertension.
    Olschewski H; Rose F; Grünig E; Ghofrani HA; Walmrath D; Schulz R; Schermuly R; Grimminger F; Seeger W
    J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled iloprost for the treatment of pulmonary hypertension.
    Olschewski H
    Eur Respir Rev; 2009 Mar; 18(111):29-34. PubMed ID: 20956120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
    Olschewski H; Ghofrani HA; Schmehl T; Winkler J; Wilkens H; Höper MM; Behr J; Kleber FX; Seeger W
    Ann Intern Med; 2000 Mar; 132(6):435-43. PubMed ID: 10733442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.
    Voswinckel R; Enke B; Reichenberger F; Kohstall M; Kreckel A; Krick S; Gall H; Gessler T; Schmehl T; Ghofrani HA; Schermuly RT; Grimminger F; Rubin LJ; Seeger W; Olschewski H
    J Am Coll Cardiol; 2006 Oct; 48(8):1672-81. PubMed ID: 17045906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension.
    de Jesus Perez VA; Rosenzweig E; Rubin LJ; Poch D; Bajwa A; Park M; Jain M; Bourge RC; Kudelko K; Spiekerkoetter E; Liu J; Hsi A; Zamanian RT
    Am J Cardiol; 2012 Nov; 110(10):1546-50. PubMed ID: 22853986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
    Schermuly RT; Inholte C; Ghofrani HA; Gall H; Weissmann N; Weidenbach A; Seeger W; Grimminger F
    Respir Res; 2005 Jul; 6(1):76. PubMed ID: 16033645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs.
    Safdar Z
    Respir Med; 2011 Jun; 105(6):818-27. PubMed ID: 21273054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.